Qiagen NV
(XTER:QIA)
€
39.125
0.3 (0.77%)
Market Cap: 8.67 Bil
Enterprise Value: 9.24 Bil
PE Ratio: 27.85
PB Ratio: 2.59
GF Score: 86/100 - Q1 2024 Qiagen NV Earnings Call TranscriptApr 30, 2024€39.08 (-0.17%)Earnings
- Qiagen NV at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Qiagen NV Earnings Call TranscriptFeb 07, 2024€40.56 (-2.28%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Qiagen NV at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Qiagen NV at Jefferies London Healthcare Conference TranscriptNov 15, 2023
- Qiagen NV at Stifel Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Qiagen NV Earnings Call TranscriptOct 31, 2023€36.21 (+5.31%)Earnings
- Qiagen NV at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2023
- Qiagen NV at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Qiagen NV Earnings Call TranscriptAug 09, 2023€42.19 (+0.86%)Earnings
- Qiagen NV Annual Shareholders Meeting TranscriptJun 22, 2023
- Qiagen NV at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Qiagen NV at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Qiagen NV Earnings Call TranscriptMay 04, 2023€43.4 (+3.36%)Earnings
- Qiagen NV at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Qiagen NV at Citi Healthcare & Medtech Conference TranscriptMar 01, 2023
- Q4 2022 Qiagen NV Earnings Call TranscriptFeb 08, 2023€48.06 (+0.97%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Qiagen NV at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Qiagen NV at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Qiagen NV Earnings Call TranscriptNov 08, 2022€45.61 (+5.28%)Earnings
- Qiagen NV at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2022
- Qiagen NV at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Qiagen NV at Goldman Sachs European Medtech and Healthcare Services Conference TranscriptSep 07, 2022
- Q2 2022 Qiagen NV Earnings Call TranscriptJul 28, 2022€49.9 (+3.35%)Earnings
- Qiagen NV Annual Shareholders Meeting TranscriptJun 23, 2022
- Qiagen NV at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Qiagen NV at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Qiagen NV at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Qiagen NV Earnings Call TranscriptApr 28, 2022€44.75 (+4.53%)Earnings
- Qiagen NV at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Qiagen NV at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Qiagen NV at Citi Healthcare Conference (Virtual) TranscriptFeb 23, 2022
- Q4 2021 Qiagen NV Earnings Call TranscriptFeb 09, 2022€45.68 (+3.05%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Qiagen NV at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Qiagen NV at Jefferies London Healthcare Conference (Virtual) TranscriptNov 16, 2021
- Q3 2021 Qiagen NV Earnings Call TranscriptNov 04, 2021€49.74 (+1.30%)Earnings
- Qiagen NV at Bank of America Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Qiagen NV at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Qiagen NV at Goldman Sachs MedTech Conference (Virtual) TranscriptSep 08, 2021
- Preliminary Q2 2021 Qiagen NV Earnings Call TranscriptJul 13, 2021€40.93 (-4.27%)Earnings
- Qiagen NV at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Qiagen NV at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- Qiagen NV at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Qiagen NV Earnings Call TranscriptMay 04, 2021€40.68 (-1.33%)Earnings
- Qiagen NV at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Qiagen NV at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Qiagen NV at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference TranscriptFeb 24, 2021
- Q4 2020 Qiagen NV Earnings Call TranscriptFeb 10, 2021€46.59 (+1.35%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Qiagen NV Virtual Deep Dive Event TranscriptDec 08, 2020
- Q3 2020 Qiagen NV Earnings Call TranscriptOct 28, 2020€43.14 (-1.11%)Earnings
- Qiagen NV Annual Shareholders Meeting TranscriptJun 30, 2020
- Thermo Fisher Scientific Inc to Acquire Qiagen NV Call TranscriptMar 03, 2020
- Q4 2019 Qiagen NV Earnings Call TranscriptFeb 05, 2020€32.94 (+4.93%)Earnings
- Qiagen NV at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Qiagen NV Earnings Call TranscriptOct 31, 2019€27.74 (+2.99%)Earnings
- Qiagen NV at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Qiagen NV Earnings Call TranscriptJul 31, 2019€35.55 (+0.79%)Earnings
- Qiagen NV Analyst and Investor Day 2019 TranscriptJun 20, 2019
- Qiagen NV Annual Shareholders Meeting TranscriptJun 17, 2019
- Qiagen NV at Jefferies Healthcare Conference TranscriptJun 04, 2019
- Q1 2019 Qiagen NV Earnings Call TranscriptMay 07, 2019€34.13 (-3.95%)Earnings
- Qiagen NV at Barclays Global Healthcare Conference TranscriptMar 14, 2019
Qiagen NV Virtual Deep Dive Event Transcript
Dec 08, 2020 / 03:30PM GMT
Release Date Price:
€43.39
(+4.39%)
Phoebe Loh
QIAGEN N.V. - Associate Director of IR
Hello, and welcome, everyone, to our Deep Dive event.
John Gilardi
QIAGEN N.V. - VP of Corporate Communications & IR
And thank you as well for me, for joining us today, and thank you as well for putting up with my hoarse voice.
Phoebe Loh
QIAGEN N.V. - Associate Director of IR
2020 has been a year of many developments and change for all of us. The COVID-19 pandemic has reached a level no one could have imagined earlier this year, and we've also had quite a year at QIAGEN as well. But in these times, never before has there been such a critical and rewarding time for our QIAGEN colleagues worldwide to achieve our vision of helping to make improvements in life possible.
John Gilardi
QIAGEN N.V. - VP of Corporate Communications & IR
Today, it's an opportunity to update you on that progress. In particular, we are going to review our strategy, provide a financial update and have a deep dive on our 5 pillars of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)